Sign in
Not yet recruitingNo phase

Quality of Life in Patients With Post-Sepsis Syndrome

Key facts

Who runs it
Efferon JSC
Where
Russia5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
300 people, planned
Started
1 Nov 2026
Expected to end
1 Nov 2029
Type of study
Observational, 2 groups
Treatments tested
  • Efferon LPS
Record updated
22 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (15)Hide the full registry criteria

Who can take part

  • Documented episode of sepsis or septic shock requiring hospitalization and treatment in an intensive care unit (ICU)
  • Sequential Organ Failure Assessment (SOFA) score ≥4 points during the ICU stay
  • Discharge from the ICU and hospital after completion of treatment for sepsis or septic shock
  • Montreal Cognitive Assessment (MoCA) score ≥26 points
  • Availability for remote follow-up during the 1-year post-sepsis period following hospital discharge
  • Ability to participate in remote visits, complete remote questionnaires (PROMIS questionnaire, depression and anxiety rating scales), and transmit them via electronic communication means
  • Ability to understand and independently complete patient-reported outcome questionnaires, or to complete them with minimal assistance
  • Availability of information regarding whether hemoadsorption with Efferon® LPS was performed during hospitalization for sepsis or septic shock
  • Signed informed consent for participation in the study and collection of follow-up data

Who cannot take part

  • Severe cognitive impairment, dementia, or other conditions that prevent the participant from understanding the questionnaire items and providing meaningful responses
  • Severe mental illness or other psychiatric conditions that, in the Investigator's opinion, may substantially affect the validity or reliability of patient-reported outcomes
  • Any other condition or circumstance that, in the Investigator's opinion, may interfere with the participant's ability to comply with study procedures or may compromise the reliability of the study data
  • Inability to maintain remote contact with the participant during the follow-up period
  • Palliative care status
  • Current participation in another clinical study that, in the Investigator's opinion, may affect the quality-of-life or psychological outcomes assessed in this study

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sepsis

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of the study is to assess health status and quality of life during the post-sepsis period using patient-reported outcome measures. Patients will be classified into two groups according to treatment received during hospitalization for sepsis or septic shock: those who received standard-of-care treatment alone and those who additionally received Efferon® LPS hemoadsorption. The study will compare post-sepsis outcomes between the two groups over a 12-month follow-up period.

The 2 groups in the trial

  • Baseline therapy

    Patients who received standard therapy for sepsis. RRT or plasma-based therapies, including plasmapheresis or plasma exchange, are permitted.

  • Baseline therapy + Efferon LPS

    Patients who received Efferon® LPS hemoadsorption during treatment for sepsis, either alone or in combination with renal replacement therapy (RRT). Concomitant plasma-based therapies, including plasmapheresis or plasma exchange, are permitted.

    Treatment: Efferon LPS

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Quality of Life in Patients With Post-Sepsis Syndrome: A Multicenter Observational Study
Criteria questions
Built from NCT07889804, who can take part
Record updated
22 October 2026